Menarini Articles
Forest launches COPD product Tudorza in USA
12 December 2012
Menarini in $1 billion partnership with Oxford BioTherapeutics for cancer drug development
29 October 2012
Menarini extends febuxostat accord to more regions
12 April 2012
Menarini succession plan sees Aleotti offspring take over
19 September 2011
Menarini strongly denies it is looking to sell or list on stock exchange
12 September 2011
Orexo licenses Abstral to Invida for in Asia Pacific: GlaxoSmithKline gets rights to bilastine in Spain and Poland
17 January 2011
Vernalis to re-acquire EU frovatriptan royalties; Isogenica gains rights to commercialize drugs with MRSA potential
15 February 2010
Ipsen grants Menarini exclusive European rights to Adenuric in up to 132 million-euro deal
20 October 2009
CV's Ranexa cleared in the UK and Germany
9 March 2009
CV's 3rd-qtr 2008 loss narrows 26% to $25.4M
17 November 2008
Nanogen links up with Menarini for diagnostics market
17 November 2008
Expanded US label for CV's angina drug
17 November 2008
UK's Vernalis gets 18.4 million euros financing
28 April 2008
Faes Farma assigns Bilastina to Menarini
24 December 2007
Vernalis' 6-month loss narrows 29%, on sales
24 September 2007
Goodwin and Menarini complete abagovomab production
16 July 2007
Oscient in EU deal with Menarini for Factive
15 January 2007
Recordat recruits Andrea Breschi as general manager, pharma Italy
25 September 2006
GMP standards soon for Russian drug firms
3 April 2006
Menarini launches Nebilet beta-blockers
20 February 2006
Italy's Menarini buys Pliva unit in Germany?
6 February 2006
Vernalis' frovatriptan available in Italy
4 October 2004
Vernalis cuts first-half 2004 loss 50%
27 September 2004
Menarini's nebivolol shows benefit in elderly heart failure patients; SENIORS study
13 September 2004
Elan completes sale of Frova to Vernalis
24 May 2004
Latvian drugs market grew 12.4% in 2003
3 May 2004
Vernalis pays Elan $55M for Frova return
5 April 2004
Berlin-Chemie is market leader in Latvia
16 February 2004
Italy's Menarini donates drugs to Iraq
15 September 2003
Menarini Baltic sales up 12%
15 September 2003
Vernalis placement lifts stock
12 May 2003
Vernalis' frovatriptan launched in UK
14 April 2003
Menarini grows R&D, opens biotech facility
17 March 2003
Berlin Chemie/Menarini boosts sales in Romania
29 April 2002
Net losses narrow at the UK's Vernalis
25 March 2002
Tanabe to form cancer JV with Menarini
11 February 2002
Tokyo pharma stocks - week to February 4
11 February 2002
Elan and Vernalis antimigraine drug wins US approval
12 November 2001
Vernalis losses deepen but US launch of frovatriptan still not imminent
19 September 2001
Tokyo pharma stocks in week to Monday March 19, 2001
21 March 2001
Vernalis full-year 2000 losses double
21 March 2001
Menarini acquires Turkey's IE Ulagay
31 January 2001
Menarini opens UK headquarters
5 October 2000
First-half 2000 net income shoots up 121.7% at Italy's Recordati
28 September 2000
Vernalis integration progressing well
19 September 2000
Vernalis wins French backing for Migard
25 July 2000
Vanguard & Menarini sign frovatriptan deal
15 September 1999
SMEs: a role model for EU candidate countries
6 July 1999
UK launch for nebivolol and Menarini
30 March 1999
Berlin-Chemie/Menarini looking to expand
3 March 1999
Strong sales growth for Menarini Spain
9 February 1999
Growth for Menarini Spain
8 February 1999
Menarini Revamp Plan Problems Sorted
13 October 1998
Chiroscience Stock Yo-Yos After Gene Discovery
7 October 1998
Sales Climb 34% At Berlin-Chemie
21 April 1998
Menarini's Dexketoprofen Selling Well
17 April 1998
EU Clears Menarini's Dexketoprofen
29 January 1998
1997: Another Good Year For New Chemical Entities
6 January 1998
EFPIA Expands Membership To Drugmakers
24 November 1997
Menarini Files In EU For Dexketoprofen
2 October 1997
What Future For Domestic Spanish Drugmakers?
7 July 1997
Chiroscience To Put Cancer Drugs In Clinic In 4Q97
17 March 1997
First Launch Of Menarini's Nebivolol
3 March 1997
Record Number Of New Chemical Entities In 1996
20 January 1997
Berlin-Chemie Revises 1996 Sales Forecast
18 November 1996
Italian Drug Prices Impact On Jobs, Says Forza Italia MP
14 October 1996
Chiroscience Gets First Product Approval
8 July 1996
Dexketoprofen Update
13 May 1996
Pilato Joins Menarini Group
29 April 1996
Mergermania In Euro Drug Industry: Will It Continue?
18 March 1996
Menarini prize
27 November 1995
Chiroscience's First Single-Isomer Drug
6 November 1995
Tripos/Menarini SRL collab
16 October 1995
Interim Sales Soar At Chiroscience
9 October 1995
Chiroscience use Ductch Elm disease enzyme
7 August 1995
Orphan Status For Mitolactol
24 July 1995
Menarini Appointments
17 July 1995
Farmindustria appoints Federico Nazzari
10 July 1995
Menarini name
19 June 1995
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
